Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

被引：36
|
作者：
Barreto, L.
Guasparini, R.
Meekison, W.
Noya, F.
Young, L.
Mills, E.
机构：
[1] Sanofi Pasteur Ltd, Toronto, ON M2R 3T4, Canada
[2] Fraser Hlth Authority, Surrey, BC V3X 3A4, Canada
[3] Westcoast Clin Res, Coquitlam, BC V3C 4J2, Canada
[4] Montreal Childrens Hosp, Div Infect Dis, Montreal, PQ H3H 1P3, Canada
来源：
VACCINE | 2007年 / 25卷 / 48期
关键词：
pertussis; vaccine; serology;
D O I：
10.1016/j.vaccine.2007.09.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Persistence of antibodies following a single dose of Tdap, vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N = 324) and adults (N = 644) who had received Tdap in earlier clinical trials. Outcome measures were seroprotection (tetanus and diphtheria) or seropositivity (pertussis) and geometric mean titers. Humoral immune responses to all antigens were robust 1 month after initial immunization; antibodies exceeded pre-immunization levels 1, 3, and 5 years later. These data will contribute to selecting the optimal interval for booster doses of Tdap. Crown Copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：8172 / 8179
页数：8
相关论文
共 50 条
  • [1] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
    Tomovici, A.
    Barreto, L.
    Zickler, P.
    Meekison, W.
    Noya, F.
    Voloshen, T.
    Lavigne, P.
    VACCINE, 2012, 30 (16) : 2647 - 2653
  • [2] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA
    Pool, Vitali
    Tomovici, Antigona
    Johnson, David R.
    Greenberg, David P.
    Decker, Michael D.
    VACCINE, 2018, 36 (17) : 2282 - 2287
  • [3] Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
    Pichichero, ME
    Rennels, MB
    Edwards, KM
    Blatter, MM
    Marshall, GS
    Bologa, M
    Wang, E
    Mills, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24): : 3003 - 3011
  • [4] Reactogenicity of Tetanus, Diphtheria, 5-Component Acellular Pertussis Vaccine Administered as a Sixth Consecutive Acellular Pertussis Vaccine Dose to Adolescents
    Liese, Johannes G.
    Rieber, Nikolaus
    Malzer, Thomas
    Ocak, Marion
    Johnson, David R.
    Decker, Michael D.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (12) : 1067 - 1071
  • [5] Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data
    Bailleux, F.
    Coudeville, L.
    Kolenc-Saban, A.
    Bevilacqua, J.
    Barreto, L.
    Andre, P.
    VACCINE, 2008, 26 (31) : 3903 - 3908
  • [6] ACELLULAR PERTUSSIS DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS BOOSTER VACCINE AT 5 YEARS OF AGE
    KANRA, G
    CEYHAN, M
    TOPAL, B
    BOGAERTS, H
    VANDEVOORDE, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (07) : 598 - 598
  • [7] An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine
    Pichichero, Michael E.
    DeTora, Lisa M.
    Johnson, David R.
    EXPERT REVIEW OF VACCINES, 2006, 5 (02) : 175 - 187
  • [8] Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
    Pichichero, ME
    Blatter, MM
    Kennedy, WA
    Hedrick, J
    Descamps, D
    Friedland, LR
    PEDIATRICS, 2006, 117 (04) : 1084 - 1093
  • [9] Immunogenicity, Safety, and Antibody Persistence at 3, 5, and 10 Years Postvaccination in Adolescents Randomized to Booster Immunization with a Combined Tetanus, Diphtheria, 5-Component Acellular Pertussis, and Inactivated Poliomyelitis Vaccine Administered with a Hepatitis B Virus Vaccine Concurrently or 1 Month Apart
    Embree, Joanne
    Law, Barbara
    Voloshen, Tim
    Tomovici, Antigona
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (03) : 282 - 290
  • [10] Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
    Weston, Wayde
    Messier, Marc
    Friedland, Leonard R.
    Wu, Xiangfeng
    Howe, Barbara
    VACCINE, 2011, 29 (47) : 8483 - 8486
12345